Trademark Search  /  PIONEERING THE DISCOVERY AND DEVELOPMENT OF NOVEL CANCER THERAPIES

PIONEERING THE DISCOVERY AND DEVELOPMENT OF NOVEL CANCER THERAPIES

○ Dead · Cancelled

U.S. federal trademark · Serial No. 77852199 · Reg. No. 3848876

Mark
PIONEERING THE DISCOVERY AND DEVELOPMENT OF NOVEL CANCER THERAPIES
Status
Cancelled
Serial Number
77852199
Registration No.
3848876
Filing Date
October 19, 2009
Registration Date
September 14, 2010
Class(es)
Class 042, Class 044

Owners

ASTEX PHARMACEUTICALS, INC.
03 · Pleasanton, CA, US
SuperGen, Inc.
03 · Dublin, CA, US
SuperGen, Inc.
03 · Dublin, CA, US
SuperGen, Inc.
03 · Dublin, CA, US

Goods & Services

Providing health care information via telephone and the Internet; Providing information in the field of the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals

Research and development services in the field of pharmaceuticals; providing medical and scientific health care research information in the field of pharmaceuticals and clinical trials

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "PIONEERING THE DISCOVERY AND DEVELOPMENT OF NOVEL CANCER THERAPIES" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.